Enteric Disease Testing Market Analysis and Forecast to 2031: By Therapeutics (Campylobacter, Cryptosporidium, E-Coli, RhinoViruses, and Others), Technology (Monoclonal Antibodies, Immunoassays, Information Technology, and Others), and Region

Enteric disease testing is a diagnostic tool used to identify infections of the gastrointestinal tract. This type of testing can be used to detect bacteria, viruses, and parasites that may cause illness. Enteric disease testing can be performed using various methods, including stool cultures, serologic testing, and polymerase chain reaction (PCR).

Key Trends

There are a few key trends in enteric disease testing technology.

One is the development of more sensitive and specific tests. This is important because it allows for earlier detection of disease and can help to improve patient outcomes.

Another trend is the use of multiple tests, which can detect multiple pathogens simultaneously. This is important because it can help to reduce the time to diagnosis and can also help to reduce the number of false-positive results.

Additionally, there is a trend toward the use of point-of-care tests, which can provide results more quickly and can be more convenient for patients.

Key Drivers

Enteric Disease Testing market is mainly driven by the increasing prevalence of enteric diseases and the rising awareness about these diseases. Enteric diseases are a group of infections that affect the intestines and are caused by viruses, bacteria, and parasites.

These diseases can lead to severe diarrhea, vomiting, and abdominal pain. In some cases, they can also lead to life-threatening complications such as dehydration, malnutrition, and sepsis.

The most common enteric diseases are cholera, typhoid fever, and gastroenteritis. These diseases are more common in developing countries where sanitation and hygiene conditions are poor.

Enteric diseases are also on the rise in developed countries due to the increasing international travel and the changing patterns of food consumption. The rising awareness about these diseases and the availability of better diagnostic tools are also driving the growth of the Enteric Disease Testing market.

Restraints & Challenges

The key restraints and challenges in the enteric disease testing market include the lack of awareness about enteric diseases, the lack of access to testing and treatment facilities, and the high cost of testing and treatment.

Other restraints and challenges include the lack of standardization of testing methods and the lack of reliable data on the prevalence of enteric diseases.

Market Segments

The Enteric Disease Testing Market is segmented by therapeutics, technology and region. By therapeutics, the market is divided  into campylobacter, cryptosporidium, e-coli, enteroviruses and rhinoviruses. Based on technology, it is monoclonal antibodies, immunoassays, information technology, and others. Region-wise the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.

Key Players

The Enteric Disease Testing Market includes players such as Alere, Inc., Becton Dickinson & Company, Biomerica, Inc., Biomerieux, Bio-Rad, Cepheid Coris Bioconcept, Diasorin, Meridian Bioscience, Quest Diagnostics and Trinity Biotech.

Why GIS?

Table of Contents

Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Enteric Disease Testing Market Outlook
3.1. Enteric Disease Testing Market segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Enteric Disease Testing Market

Chapter 4. Economic Impact of COVID-19 on Enteric Disease Testing Market
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Enteric Disease Testing Market
4.3. Economic Impact Analysis

Chapter 5. Enteric Disease Testing Market by Therapeutics
5.1. Market Overview
5.2. Campylobacter
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Cryptosporidium
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.4. E-Coli
5.4.1. Market Size and Forecast, 2021-2031 ($Million)
5.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.5. Rhino Viruses
5.5.1. Market Size and Forecast, 2021-2031 ($Million)
5.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.6. Others
5.6.1. Market Size and Forecast, 2021-2031 ($Million)
5.6.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 6. Enteric Disease Testing Market by Technology
6.1. Market Overview
6.2. Monoclonal Antibodies
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Immunoassays
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.4. Information Technology
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.5. Others
6.5.1. Market Size and Forecast, 2021-2031 ($Million)
6.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 7. Enteric Disease Testing Market, by Region
7.1. Overview
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. North America Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.2.3. North America Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.2.4. North America Enteric Disease Testing Market Size and Forecast by Country, 2021-2031, ($Million)
7.2.5. The U.S.
7.2.5.1. The U.S. Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.2.5.2. The U.S. Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.2.6. Canada
7.2.6.1. Canada Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.2.6.2. Canada Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.2.7. Mexico
7.2.7.1. Mexico Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.2.7.2. Mexico Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Europe Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.3.3. Europe Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.3.4. Europe Enteric Disease Testing Market Size and Forecast by Country, 2021-2031, ($Million)
7.3.5. Germany
7.3.5.1. Germany Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.3.5.2. Germany Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.3.6. France
7.3.6.1. France Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.3.6.2. France Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.3.7. U.K.
7.3.7.1. U.K. Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.3.7.2. U.K. Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.3.8. Spain
7.3.8.1. Spain Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.3.8.2. Spain Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.3.9. Italy
7.3.9.1. Italy Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.3.9.2. Italy Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.3.10. Rest of Europe
7.3.10.1. Rest of Europe Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.3.10.2. Rest of Europe Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Asia-Pacific Enteric Disease Testing Market Size and Forecast by Country, 2021-2031, ($Million)
7.4.3. Asia-Pacific Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.4.4. Asia-Pacific Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.4.5. China
7.4.5.1. China Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.4.5.2. China Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.4.6. India
7.4.6.1. India Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.4.6.2. India Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.4.7. Japan
7.4.7.1. Japan Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.4.7.2. Japan Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.4.8. South Korea
7.4.8.1. South Korea Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.4.8.2. South Korea Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.4.9. Rest of APAC
7.4.9.1. Rest of APAC Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.4.9.2. Rest of APAC Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.5. Rest of the World
7.5.1. Key Market Trends and Opportunities
7.5.2. Rest of the World Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.5.3. Rest of the World Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.5.4. Rest of the World Enteric Disease Testing Market Size and Forecast by Country, 2021-2031, ($Million)
7.5.5. Latin America
7.5.5.1. Latin America Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.5.5.2. Latin America Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.5.6. Middle East
7.5.6.1. Middle East Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.5.6.2. Middle East Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)
7.5.7. Africa
7.5.7.1. Africa Enteric Disease Testing Market Size and Forecast by Therapeutics, 2021-2031, ($Million)
7.5.7.2. Africa Enteric Disease Testing Market Size and Forecast by Technology, 2021-2031, ($Million)

Chapter 8. Competitive Landscape
8.1. Market Overview
8.2. Market Share Analysis/Key Player Positioning
8.3. Developmental Strategy Benchmarking
8.3.1. New Product Development
8.3.2. Product Launches
8.3.3. Business Expansions
8.3.4. Partnerships, Joint Ventures, and Collaborations
8.3.5. Mergers and Acquisitions

Chapter 9. Company Profiles
9.1. Alere, Inc.
9.1.1. Company Snapshot
9.1.2. Financial Performance
9.1.3. Product Offerings
9.1.4. Key Strategic Initiatives
9.1.5. SWOT Analysis
9.2. Becton Dickinson & Company
9.2.1. Company Snapshot
9.2.2. Financial Performance
9.2.3. Product offerings
9.2.4. Key Strategic Initiatives
9.2.5. SWOT Analysis
9.3. Biomerica, Inc.
9.3.1. Company Snapshot
9.3.2. Financial Performance
9.3.3. Product offerings
9.3.4. Key Strategic Initiatives
9.3.5. SWOT Analysis
9.4. Biomerieux
9.4.1. Company Snapshot
9.4.2. Financial Performance
9.4.3. Product offerings
9.4.4. Key Strategic Initiatives
9.4.5. SWOT Analysis
9.5. Bio-Rad
9.5.1. Company Snapshot
9.5.2. Financial Performance
9.5.3. Product offerings
9.5.4. Key Strategic Initiatives
9.5.5. SWOT Analysis
9.6. Cepheid Coris Bioconcept
9.6.1. Company Snapshot
9.6.2. Financial Performance
9.6.3. Product offerings
9.6.4. Key Strategic Initiatives
9.6.5. SWOT Analysis
9.7. Diasorin
9.7.1. Company Snapshot
9.7.2. Financial Performance
9.7.3. Product offerings
9.7.4. Key Strategic Initiatives
9.7.5. SWOT Analysis
9.8. Meridian Bioscience
9.8.1. Company Snapshot
9.8.2. Financial Performance
9.8.3. Product offerings
9.8.4. Key Strategic Initiatives
9.8.5. SWOT Analysis
9.9. Quest Diagnostics
9.9.1. Company Snapshot
9.9.2. Financial Performance
9.9.3. Product offerings
9.9.4. Key Strategic Initiatives
9.9.5. SWOT Analysis
9.10. Trinity Biotech
9.10.1. Company Snapshot
9.10.2. Financial Performance
9.10.3. Product offerings
9.10.4. Key Strategic Initiatives
9.10.5. SWOT Analysis

*The list of company is subject to change during the final compilation of the report

 

 

 

Market Segments

By Therapeutics

  • Campylobacter
  • Cryptosporidium
  • E-Coli
  • Rhino Viruses
  • Others

By Technology

  • Monoclonal Antibodies
  • Immunoassays
  • Information Technology
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

An aptamer is a single-stranded nucleic acid molecule…
Migraine is a neurological disorder that is associated…
Acromegaly is a rare hormonal condition that results…
Asthma is a chronic inflammatory disease of the…
Animal intestinal health is the overall health of…
Radiation oncology is a branch of medicine that…
Over-the-counter (OTC) drugs are medications that can be…
Dry eye syndrome (DES) is a condition that…
Crohn's disease is a type of inflammatory bowel…
The H1N1 flu (swine flu) is primarily caused…